Das internationale Endometriose-Evaluationsprogramm (IEEP) – eine Studie für Kliniker, Forscher und Patientinnen

In: Geburtshilfe und Frauenheilkunde · 2020 · doi:10.1055/s-0040-1714019 · W4231381714
article OA: closed CC0
View on OpenAlex View at publisher
AI-generated summary by claude@2026-06, 2026-06-08

The International Endometriosis Evaluation Program (IEEP) aims to systematically collect data and follow patients to develop diagnostic and predictive tests for individualized treatment of endometriosis.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

AI-generated deep summary by claude@2026-06, 2026-06-08

This paper describes the development of the International Endometriosis Evaluation Programme (IEEP), a multicenter, web-based documentation system intended for structured follow-up and biomarker collection in women with intraoperatively diagnosed endometriosis. Using an Oracle-based database with electronic case report forms, it has enrolled more than 12,000 patients across Europe (from February 2014 to the time of writing), capturing patient characteristics, symptoms and clinical features, diagnostic procedures, operative data, and therapies. The authors report that preliminary analyses defined endometriosis subgroups based on spread and analyzed associated patient characteristics, while the broader goal is to develop diagnostic and predictive biomarker tests that could reduce reliance on operative diagnostic steps and predict treatment response. This paper is centrally about endometriosis — specifically, it presents the IEEP cohort and biomarker-follow-up program aimed at improving understanding, classification, and future diagnostics in endometriosis.

Read from the paper's body, not the abstract. Not a substitute for reading the paper. No clinical advice. How this works

Abstract

Einleitung: Die Endometriose ist mit ihren vielseitigen Erscheinungsformen ein Chamäleon unter den Erkrankungen. Eine eindeutige Ätiologie ist bislang nicht bekannt und die Heterogenität der klinischen Symptomatik erschwert die frühzeitige Diagnose und Therapie. Eine mögliche Antwort auf diese Problematik könnte die systematische Erfassung und Erhebung eines strukturierten Follow-up sein. Zudem soll die Untersuchung von Biomarkern zur Entwicklung von diagnostischen und prädiktiven Tests führen, mit deren Hilfe Patientinnen individualisiert operativ oder medikamentös therapiert werden können.

My notes (saved in your browser only)

Condition tags

die_deep_infiltrating

Citation neighborhood (no data yet)

We don't have any in-corpus citations linked to this paper yet. The paper's references may be in our DB but unresolved to ``paper_id`` (resolution happens at ingest when the cited DOI matches a row we already have). Run the cross-source citation reconcile pass to retry.

Source provenance

openalex
last seen: 2026-06-10T17:14:06.276822+00:00
License: CC0 · commercial use OK